Rituximab exposure‐response in triweekly R‐CHOP treatment in DLBCL: A loading dose is recommended to improve clinical outcomes

Previous exposure‐response analyses for rituximab suggest that higher rituximab concentrations were associated with an improvement in efficacy, however, clinical studies investigating a higher rituximab dose had mixed results. To further explore the exposure‐response relationship of rituximab, a pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shu, Wang, Zhao, Chen, Rongxin, Huang, He, Wang, Xueding, Peng, Chen, Guan, Yanping, Fang, Xiaojie, Guan, Shaoxing, Huang, Hongbing, Liu, Tao, Lin, Tongyu, Huang, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932720/
https://www.ncbi.nlm.nih.gov/pubmed/34729920
http://dx.doi.org/10.1111/cts.13186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932720/
https://www.ncbi.nlm.nih.gov/pubmed/34729920
http://dx.doi.org/10.1111/cts.13186

Ejemplares similares